Tonix Pharmaceuticals(us:TNXP)
0.4039
-33.96%
Updated on 2024-12-23
Open:0.5018
Close:0.4039
High:0.5297
Low:0.3960
Pre Close:0.6116
Volume:165.17M
Amount:75.83M
Turnover:88.37%
Shares:186.89M
MarketCap:75.49M
About Tonix Pharmaceuticals Company
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.
Company Name: Tonix Pharmaceuticals
Company Address: 26 Main Street,Suite 101
Employees: 103
Fiscar Year: 12-31
IPO Date: 2013-08-09
Website: http://www.tonixpharma.com
CIK: 1430306
View all SEC Filings
About
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.
Address:26 Main Street,Suite 101
Website:http://www.tonixpharma.com
Market Movers